We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

High sdLDL-C and Lipoprotein(A) Levels Correlated to Coronary Arteriostenosis in Takayasu Arteritis

By LabMedica International staff writers
Posted on 11 Nov 2021
Print article
Image: The Beckman AU5400 automatic biochemical analyzer (Photo courtesy of Beckman Coulter)
Image: The Beckman AU5400 automatic biochemical analyzer (Photo courtesy of Beckman Coulter)
Takayasu arteritis (TA) is a rare vasculitis that mainly involves the aorta and its major branches. TA is mainly seen in young women aged 20–40 years and is most often encountered in Japan, Southeast Asia, India, and Mexico. Due to nonspecific clinical features, TA patients with coronary arteriostenosis might be misdiagnosed or inappropriately treated.

Dyslipidemia plays a role in the pathogenesis of TA, and the lipid profiles in TA patients are pro-atherogenic. Small dense low-density lipoprotein cholesterol (sdLDL-C) is small and highly dense relative to other LDL-C particles and thought to be more atherogenic than the large buoyant LDL (lb-LDL) due to greater penetration into the arterial wall, a prolonged plasma half-life, lower hepatic LDL receptor affinity, and higher susceptibility to oxidation.

Clinical Laboratorians at the Capital Medical University (Beijing, China) retrospectively studied 190 TA patients and 154 healthy subjects. TA patients were divided into three categories based on the degree of coronary stenosis: Group I, stenosis >50%; Group II, stenosis 1%–50%; and Group III, stenosis 0%. Independent risk factors for coronary arteriostenosis in TA were identified by logistic regression, followed by receiver operating characteristic curve analysis to determine the specificity and sensitivity of risk factors and Youden's Index score calculation to determine the cutoff points.

The team obtained early in the morning, venous blood samples were from fasting TA patients and healthy controls. The team previously compared methods for measuring sdLDL-C, and a Beckman AU5400 automatic biochemical analyzer (Beckman Coulter, Brea, CA, USA) and was used in the present study to measure novel and traditional lipid parameters and biochemical indicators, including the sdLDL-C, Lp(a), total cholesterol (TC), LDL-C, HDL-C, and triglyceride (TG) concentrations within 5–6 hours after sample collection. The Sysmex XE-2100 (Sysmex Corporation, Kobe, Japan) was used to determine complete blood counts.

The investigators reported Takayasu arteritis patients had significantly higher serum levels of sdLDL-C and Lp(a) than healthy controls. The total cholesterol, triglyceride, LDL-C, sdLDL-C, and Lp(a) levels and the sdLDL-C/LDL-C ratio in Group I were significantly higher than those in Groups II and III. An elevated serum sdLDL-C level elevated the risk of coronary arteriostenosis by 5-fold (cutoff value, 0.605 mmol/L). An increased serum Lp(a) level increased the risk of coronary arteriostenosis by 3.9-fold (cutoff value, 0.045 g/L). An elevated sdLDL-C/LDL-C ratio increased the risk of coronary arteriostenosis by 2.1-fold (cutoff value, 0.258).

The authors concluded that TA patients had higher serum sdLDL-C and Lp(a) concentrations than healthy individuals and TA patients with coronary arteriostenosis had significantly higher serum levels of sdLDL-C and Lp(a) than those without coronary arteriostenosis. Additionally, serum sdLDL-C and Lp(a) concentrations and the sdLDL-C/LDL-C ratio might be used as diagnostic factors for coronary arteriostenosis in TA patients. The study was published on October 28, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Capital Medical University
Beckman Coulter
Sysmex Corporation

Gold Supplier
Fully Automated Batch Immunoanalyzer
Bulk Sorter
Flu A/B Antibodies and Antigens
HyTest Flu A/B Antibodies and Antigens
Anti-SARS-CoV-2 Controls Kit
ACCURUN Anti-SARS-CoV-2 Controls Kit

Print article


Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more


view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more


view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more


view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more


view channel

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.